Evidence map›Paper›PMID 38355787›Full record

ArticleMolecular psychiatry2024

Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders.

Dora Koller, Eleni Friligkou, Brendan Stiltner, Gita A Pathak, Solveig Løkhammer, Daniel F Levey, Hang Zhou, Alexander S Hatoum, Joseph D Deak, Rachel L Kember and 6 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Genetic pleiotropy differentially linking brain variation to cannabis use and cannabis use disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Dora KollerDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA. dora.koller@yale.edu.ORCID 0000-0002-0415-0466
Eleni FriligkouDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID 0009-0003-3682-0991
Brendan StiltnerDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Gita A PathakDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Solveig LøkhammerDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Daniel F LeveyDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0001-8431-9569
Hang ZhouDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-7694-6391
Alexander S HatoumDepartment of Psychological and Brain Sciences, Washington University in Saint Louis, St. Louis, MO, USA.ORCID 0000-0002-8002-7267
Joseph D DeakDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-0540-6080
Rachel L KemberDepartment of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0001-8820-2659
Jorien L TreurDepartment of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Henry R KranzlerDepartment of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0002-1018-0450
Emma C JohnsonDepartment of Psychiatry, Washington University School of Medicine, Saint Louis, MO, USA.ORCID 0000-0003-0394-777X
Murray B SteinDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0001-9564-2871
Joel GelernterDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.ORCID 0000-0002-4067-1859
Renato PolimantiDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA. renato.polimanti@yale.edu.ORCID 0000-0003-0745-6046

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
RESEARCH TRAINING - BIOLOGICAL SCIENCEST32MH014276 · NIMH · YALE UNIVERSITY · PI Marina R Picciotto · 1985 to 2026
$7.2M
Leveraging genomic data to dissect the association of internalizing disorders with the risk, onset, and vulnerability of COVID-19RF1MH132337 · NIMH · YALE UNIVERSITY · PI POLIMANTI, RENATO · 2022 to 2022
$3.7M
Investigating the Systems Genetics of the Patterns of Polysubstance Abuse and AddictionR33DA047527 · NIDA · YALE UNIVERSITY · PI POLIMANTI, RENATO · 2021 to 2023
$2.0M
Translational Alcohol Research Program (TARP)T32AA028259 · NIAAA · YALE UNIVERSITY · PI COSGROVE, KELLY P., VASILIOU, VASILIS · 2020 to 2024
$1.8M
Identifying genetic sources of comorbidity between cannabis and schizophrenia using genome-wide and integrative omics dataK01DA051759 · NIDA · WASHINGTON UNIVERSITY · PI JOHNSON, EMMA COVEY · 2021 to 2025
$816k
Multi-modal intersection of depression and genetic liability to Alzheimers diseaseR00AG078503 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Gita A Pathak · 2024 to 2026
$741k
Genome-wide Investigation of the Interplay Between Age-Related Hearing Loss and Smoking BehaviorsR21DC018098 · NIDCD · YALE UNIVERSITY · PI POLIMANTI, RENATO · 2019 to 2021
$440k
Multi-modal intersection of depression and genetic liability to Alzheimers diseaseK99AG078503 · NIA · YALE UNIVERSITY · PI PATHAK, GITA A · 2022 to 2023
$203k
Alzheimer's Association AARF-22-967171EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) 101028810NCATS NIH HHS UL1 TR001863NIAAA NIH HHS T32 AA028259NIA NIH HHS K99 AG078503NIA NIH HHS R00 AG078503NIDA NIH HHS K01 DA051759NIDA NIH HHS R33 DA047527NIDCD NIH HHS R21 DC018098NIMH NIH HHS RF1 MH132337NIMH NIH HHS T32 MH014276U.S. Department of Health & Human Services | National Institutes of Health (NIH) R33 DA047527, R21 DC018098, RF1 MH132337
6 · The paper itself

Abstract

Individuals suffering from chronic pain develop substance use disorders (SUDs) more often than others. Understanding the shared genetic influences underlying the comorbidity between chronic pain and SUDs will lead to a greater understanding of their biology. Genome-wide association statistics were obtained from the UK Biobank for multisite chronic pain (MCP, N

Indexed as

Chronic PainGenetic PleiotropyGenome-Wide Association StudyPolymorphism, Single NucleotideSubstance-Related DisordersAdultAlcoholismComorbidityFemaleGenetic Predisposition to DiseaseHumansMaleMarijuana AbuseMendelian Randomization AnalysisMiddle AgedOpioid-Related Disorders

Identifiers

PMID38355787
PMCPMC11324857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.